Dispersant tablets of honeysuckle flower and coptis
A technology of dispersible tablets and Yinhuang, which is applied in the direction of medical preparations containing active ingredients, plant/algae/fungus/moss components, plant raw materials, etc., can solve the problem that Yinhuang dispersible tablets have no disintegration time, and achieve room for maneuver Great effect of improving disintegration
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0055] Chinese medicine raw materials of Yinhuang Dispersible Tablets: 100 grams of honeysuckle extract, 40 grams of Scutellaria baicalensis extract.
[0056] The weight percentage of traditional Chinese medicine extract and auxiliary materials of Yinhuang dispersible tablet: 35% of fine powder of Yinhuang extract, 22% of low-substituted hydroxypropyl cellulose, 16% of sodium carboxymethyl starch, 4% of microcrystalline cellulose, lactose 18%, Polyvinylpyrrolidone 3%, Magnesium Stearate 2%.
[0057] Yinhuang dispersible tablets are obtained according to the following specific steps: take honeysuckle, add water to decoct twice, each time for 2 hours, combine the decoction, filter, add lime milk to the filtrate to adjust the pH value to 10-12, let it stand, and filter Precipitate, add appropriate amount of water, add sulfuric acid to adjust the pH value to 6-7, stir well, filter, concentrate the filtrate to a thick paste, and dry to obtain the honeysuckle extract. Take Scutella...
Embodiment 2
[0060] The fine powder of silvery yellow extract in percentage by weight 27%, sodium carboxymethylcellulose 22%, microcrystalline cellulose 11%, cross-linked polyvinylpyrrolidone 16%, polyvinylpyrrolidone 5%, lactose 12%, polyvinylpyrrolidone 4%, micronized silica gel 1%, magnesium lauryl sulfate 2%. All the other are with embodiment 1.
Embodiment 3
[0062] 38% by weight of fine powder of silver yellow extract, 20% sodium carboxymethyl starch, 15% croscarmellose sodium, 6% crospovidone, 3% low-substituted hydroxypropyl cellulose, Mannitol 7%, polyvinylpyrrolidone 7%, micronized silica gel 2%, magnesium stearate 1%, HLB=15-16 sucrose fatty acid ester 1%. Sucrose fatty acid ester is P-1570 or P-1670 or LWA-1570, all the other are the same as embodiment 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com